sglt2 inhibitors and glp-1 receptor agonists together Blood pressure effects of GLP‐1 agonists: Mechanisms, trial evidence and Real‐world data - Belančić - British Journal of Clinical Pharmacology GLP-1 Receptor Agonists Among Patients

The 2024 structural study in Cell Research examined receptor recognition across GLP-1R, GIPR, and GCGR and reported that triple agonism involves conserved interactions along with receptor-specific contacts in the transmembrane domain pocket

Universidad de Barcelona, Spain Despite recent advancements in the field of neuro-ophthalmology, the rising rates of neurological and ophthalmological conditions, mismatches between supply and demand of clinicians, and an aging population underscore the urgent need to explore new therapeutic approaches within the field

Find out what sets the two apart and how they can promote weight loss as a part of a clinician-guided metabolic reset

Teng RL, Wang H, Sun BC, Cai DP, He YM

Bahnson JL, Knowler WC, Bantle JP, Bertoni AG, Bray GA, Chen H et al (2014) Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial